Skip to main content

MobilitySafe: Increasing safety and sustainability of micro-mobility modes in pandemic

The MobilitySafe project aims to develop a map-based tool to help individuals navigate cities in times of pandemic and conflict.

Cycling in India

In times of pandemic and conflict public transport and vehicle sharing services are frequently halted or avoided, and many people turn to cycling or walking for small distances. By partnering and working with urban development companies and agencies, such as GIZ India and Deloitte India, alongside local authorities, MobilitySafe aims to provide an open app and web-based utility to help users determine safe walking and cycling routes that avoid transmission spots or conflict zones.

Led by Dr Devanjan Bhattacharya, Train@ed Research Fellow, the project will initially focus on the Indian pilot cities of Bhuvaneshwar and New Delhi, which were selected by the German Government for special support on their way to becoming Smart Cities.

The Motibility Dashboard is available on the PeaceTech Website.

MobilitySafe is funded by the ESRC Impact Acceleration Account scheme.

Adaptive traffic signal control for developing countries using fused parameters derived from crowd-source data 
Sumit Mishra, Vishal Singh, Ankit Gupta, Devanjan Bhattacharya & Abhisek Mudgal, Transportation Letters (2022) DOI: 
View paper (First 50 readers can access full paper for free on Taylor & Francis website)

Micro-mobility routing architecture in COVID19 era for safe and smart navigation
Devanjan Bhattacharya, Presented at: Google Summit Geo for Good 2021, Slide 10, 2021
View poster

Application-Based COVID-19 Micro-Mobility Solution for Safe and Smart Navigation in Pandemics
Mishra, Sumit, Nikhil Singh, and Devanjan Bhattacharya. In: ISPRS International Journal of Geo-Information 10, no. 8: 571, 2021.
View article

An interactive tracker for ceasefires in the time of COVID-19
Allison, John; Badanjak, Sanja; Bach, Benjamin; Bell, Christine; Bhattacharya, Devanjan; Knaussel, Fiona; Wise, Laura. In: The Lancet Infectious Diseases, 14.12.2020.
View letter